BENJAMIN MUSHER to Neoadjuvant Therapy
This is a "connection" page, showing publications BENJAMIN MUSHER has written about Neoadjuvant Therapy.
Connection Strength
0.544
-
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. Ann Surg. 2022 01 01; 275(1):45-53.
Score: 0.163
-
National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer. J Surg Res. 2019 05; 237:41-49.
Score: 0.133
-
Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res. 2018 06; 226:15-23.
Score: 0.124
-
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048). J Clin Oncol. 2023 07 20; 41(21):3724-3734.
Score: 0.045
-
Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023 Jul 27; 389(4):322-334.
Score: 0.045
-
Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma. J Natl Compr Canc Netw. 2019 02; 17(2):161-168.
Score: 0.033